Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
Open Access
- 15 September 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (6) , 753-760
- https://doi.org/10.1086/520991
Abstract
Gram-negative organisms have become increasingly resistant to both β-lactam antibiotics and fluoroquinolones. Consequently, aminoglycoside antibioticKeywords
This publication has 13 references indexed in Scilit:
- Acute Renal Failure in Critically Ill PatientsA Multinational, Multicenter StudyJAMA, 2005
- Experience with a once-daily aminoglycoside program administered to 2,184 adult patientsAntimicrobial Agents and Chemotherapy, 1995
- Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapyAntimicrobial Agents and Chemotherapy, 1993
- Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic MonitoringThe Journal of Infectious Diseases, 1993
- Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infectionsJournal of Antimicrobial Chemotherapy, 1991
- Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in manJournal of Antimicrobial Chemotherapy, 1991
- Once-daily dosing regimen for aminoglycoside plus β-Lactam combination therapy of serious bacterial infections: Comparative trial with netilmicin plus ceftriaxoneThe American Journal of Medicine, 1990
- The Influence of Tobramycin Dosage Regimens on Nephrotoxicity, Ototoxicity, and Antibacterial Efficacy in a Rat Model of Subcutaneous AbscessThe Journal of Infectious Diseases, 1988
- Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory ConcentrationThe Journal of Infectious Diseases, 1987
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971